Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

COVID-VIT-D, 2022 NCT04552951

Vitamin D (n=274) vs. control (n=269)

randomized controlled trial   high risk of bias

Studied treatment

oral bolus of cholecalciferol (100,000 IU) administered at hospital admission

Control treatment

No vitamin D

Patients

COVID-19 severe or critically

Method

open-label

multicentre, international

Remark